Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Ashworth

Showing results (51-60 of 434) with videos related to

Pageof 44
Sort By:
The Oncologist|June 19, 2016
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic OpportunitiesMallika Dhawan, Charles J Ryan, Alan Ashworth
BMC Molecular Biology|October 24, 2002
Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell lineParaic A Kenny, Tariq Enver, Alan Ashworth
Nature Reviews. Clinical Oncology|August 12, 2010
Making the best of PARP inhibitors in ovarian cancerSusana Banerjee, Stan B Kaye, Alan Ashworth
Critical Reviews in Oncology/Hematology|December 10, 2016
PARP inhibitor combination therapyAmy Dréan, Christopher J Lord, Alan Ashworth
Cell Cycle (Georgetown, Tex.)|July 8, 2008
Dissecting resistance to endocrine therapy in breast cancerChristopher J Lord, Elizabeth Iorns, Alan Ashworth
The Biochemical Journal|November 4, 2008
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitizationElizabeth Iorns, Christopher J Lord, Alan Ashworth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Targeting the double-strand DNA break repair pathway as a therapeutic strategyChristopher J Lord, Michelle D Garrett, Alan Ashworth
NPJ Breast Cancer|April 6, 2023
Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathologyDivneet Mandair, Jorge S Reis-Filho, Alan Ashworth
Cancer Cell|September 10, 2014
DAISY: picking synthetic lethals from cancer genomesColm J Ryan, Christopher J Lord, Alan Ashworth
Current Opinion in Genetics & Development|March 18, 2008
DNA repair deficiency as a therapeutic target in cancerSarah A Martin, Christopher J Lord, Alan Ashworth
Pageof 44

Showing results (51-60 of 434) with videos related to

Sort By:
Pageof 44
The Oncologist|June 19, 2016
DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic OpportunitiesMallika Dhawan, Charles J Ryan, Alan Ashworth
BMC Molecular Biology|October 24, 2002
Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell lineParaic A Kenny, Tariq Enver, Alan Ashworth
Nature Reviews. Clinical Oncology|August 12, 2010
Making the best of PARP inhibitors in ovarian cancerSusana Banerjee, Stan B Kaye, Alan Ashworth
Critical Reviews in Oncology/Hematology|December 10, 2016
PARP inhibitor combination therapyAmy Dréan, Christopher J Lord, Alan Ashworth
Cell Cycle (Georgetown, Tex.)|July 8, 2008
Dissecting resistance to endocrine therapy in breast cancerChristopher J Lord, Elizabeth Iorns, Alan Ashworth
The Biochemical Journal|November 4, 2008
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitizationElizabeth Iorns, Christopher J Lord, Alan Ashworth
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Targeting the double-strand DNA break repair pathway as a therapeutic strategyChristopher J Lord, Michelle D Garrett, Alan Ashworth
NPJ Breast Cancer|April 6, 2023
Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathologyDivneet Mandair, Jorge S Reis-Filho, Alan Ashworth
Cancer Cell|September 10, 2014
DAISY: picking synthetic lethals from cancer genomesColm J Ryan, Christopher J Lord, Alan Ashworth
Current Opinion in Genetics & Development|March 18, 2008
DNA repair deficiency as a therapeutic target in cancerSarah A Martin, Christopher J Lord, Alan Ashworth
Pageof 44